Will the U.S. Remain Supreme Against Emerging Markets?

With global markets being dragged down by a slowing China, many are worried about the spillover effect into other developing economies. Unfortunately for emerging market investors, the negative effects wouldn't be the start of underperformance. For a decade, emerging market equities have lagged those of developing markets.


How did this happen? Are emerging market equities now a bargain? In his latest quarterly letter, GMO's Jeremy Grantham (Trades, Portfolio) pondered the same question:


"Relative to what we were thinking five years ago, emerging equities have done surprisingly badly, and the U.S. equity market has done surprisingly well. Was that the luck of the draw, which has no bearing on future returns? Was it a temporary phenomenon that will soon reverse? Or does it tell us something important about emerging being a value trap and/or the U.S. being extraordinary that we need to take into account in our forecasting of the future?"



To estimate whether a stock is overvalued or undervalued as a whole, Grantham typically recommends calculating a true book value and estimating a typical, long-term ROE. While this is easier said than done, it allows investors to know what they're paying for the business in comparison to its current value, while also placing a premium or discount on shares based on future growth.

One of the biggest contributors to the decade-long fall of emerging markets has been a decline in ROEs. If a company can't earn as much on its asset base, shares are of course worth less. GMO has done their best to calculate a "normalized" ROE for emerging markets, and it's remarkably close to today's actual rates. This suggests the last decade of ROE declines may not be an anomaly.

Even worse, emerging markets typically can't retain 100% of their returns on equity. For example, many firms need to divert returns not just to shareholders, but to other stakeholders such as government projects (Grantham gives the example of Gazprom and Russia). This makes actual emerging market returns much less than the theoretical return on equity. Over the past 20 years, GMO estimates that real local returns on emerging market stocks has been roughly half of what typically can be expected of a firm retaining all of its profits.

So, the decade-long decline of emerging market equities may be largely warranted, due to diminishing returns and an inability for those companies to utilize those returns. Relative weakness to U.S. markets, however, may have less to do with emerging markets than with the U.S. itself.